First Time Loading...
Y

Yonghe Medical Group Co Ltd
HKEX:2279

Watchlist Manager
Yonghe Medical Group Co Ltd
HKEX:2279
Watchlist
Price: 1.2 HKD 4.35% Market Closed
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Yonghe Medical Group Co Ltd

Wall Street analysts forecast Yonghe Medical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Yonghe Medical Group Co Ltd is 5.79 HKD with a low forecast of 2.42 HKD and a high forecast of 9.28 HKD.

Lowest Forecast
Wall Street Target
2.42 HKD
102% Upside
Average Forecast
Wall Street Target
5.79 HKD
383% Upside
Highest Forecast
Wall Street Target
9.28 HKD
674% Upside
Lowest
Price Target
2.42 HKD
102% Upside
Average
Price Target
5.79 HKD
383% Upside
Highest
Price Target
9.28 HKD
674% Upside
Yonghe Medical Group Co Ltd Competitors:
Price Targets
300143
INKON Life Technology Co Ltd
25% Upside
ASTERDM
Aster DM Healthcare Ltd
42% Upside
NH
Narayana Hrudayalaya Ltd
17% Upside
P
PR9
Praram 9 Hospital PCL
14% Upside
300143
INKON Life Technology Co Ltd
25% Upside
ASTERDM
Aster DM Healthcare Ltd
42% Upside
NH
Narayana Hrudayalaya Ltd
17% Upside
P
PR9
Praram 9 Hospital PCL
14% Upside
B
BH
Bumrungrad Hospital PCL
18% Upside
JYNT
Joint Corp
2% Downside
2120
Wenzhou Kangning Hospital Co Ltd
121% Upside
A
AEVS
Aevis Victoria SA
47% Upside

Revenue
Forecast

Revenue Estimate
Yonghe Medical Group Co Ltd

For the last 4 years the compound annual growth rate for Yonghe Medical Group Co Ltd's revenue is 10%. The projected CAGR for the next 2 years is 22%.

10%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Yonghe Medical Group Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
66%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Yonghe Medical Group Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Yonghe Medical Group Co Ltd's stock price target?
Price Target
5.79 HKD

According to Wall Street analysts, the average 1-year price target for Yonghe Medical Group Co Ltd is 5.79 HKD with a low forecast of 2.42 HKD and a high forecast of 9.28 HKD.

What is Yonghe Medical Group Co Ltd's Revenue forecast?
Projected CAGR
22%

For the last 4 years the compound annual growth rate for Yonghe Medical Group Co Ltd's revenue is 10%. The projected CAGR for the next 2 years is 22%.

ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.